Blogging the Trends from ASHI 2017

26/10/2017

ASHI was also very educational for us and proved to be an excellent platform to identify the current trends in the HLA field. All the scientific presentations at the conference were outstanding, and provided us with a better understanding on what the HLA community is working on. We noticed that...

HLA and The City – Omixon at ASHI 2017

24/10/2017

First of all, thank you to all our customers, distributors, friends and everyone else for visiting us and joining our events during the 43rd Annual ASHI 2017 Meeting! This year the Omixon Team – Efi, Maggi, Ellia, Nora, Kriszta, Pete, Faisal, Marcello and Attila – went on a trip to...

Omixon and Promovendo Form Partnership in Brazil

19/10/2017

Omixon is pleased to announce an Exclusive Distribution and Support Partnership with Promovendo, headquarted in Brazil. “Promovendo’s dedication, rich experience and extended network within the HLA-typing field will make them an excellent asset to the Omixon team. We believe the transplantation community will stand to benefit from Omixon’s world leading...

Automated NGS-based HLA Typing for Solid Organs at the 43rd ASHI Annual Meeting 2017

11/09/2017

Omixon announce that Holotype HLA and other Omixon products will be featured among eight posters produced by customers or collaborators at the annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI) in San Francisco, CA. Additionally, Omixon’s Lunchtime Symposium on Thursday will focus on NGS for solid organ...

Omixon at BSHI 2017 – EFI Accreditation with NGS in an NHS Lab

08/09/2017

Join Afshan Ali (Sales Manager, EMEA, Omixon), Nina Lauterbach, PhD (Field Application Scientist, Omixon) and our Guest Speaker, Dr. Brendan Clarke (HLA Lab Director, Leeds St. James’s University Hospital) for a 20 minute Lunchtime Workshop at BSHI 2017 in Leamington Spa, UK. Title: EFI Accreditation with NGS in an NHS...